Anivana Pharma ApS

CVR 46423283 · Private limited company (ApS) · Active · Medium risk

Anivana Pharma ApS is a Private limited company (ApS), founded on , based in Helsinge. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. CEO: Martin Caspersen.

Bankruptcy risk for Anivana Pharma ApS

2.6%
probability of bankruptcy within 12 months
Medium risk

1.9 × the average (1.41%) · higher risk than 86% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports0 · bankruptcy rate 16.7%1.9×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Time since new CEO0.5–1 yrs · bankruptcy rate 15.6%1.8×
Age (years)< 1 yrs · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×

Reduces the risk

Moves in the last 2 years0 · bankruptcy rate 7.4%0.84×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
46423283
Status
Active
Company type
Private limited company (ApS)
Founded
(0 years)
Address
Troldehøj 4
3200 Helsinge
Municipality
Gribskov
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 20k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 0
Missing annual reportNo
Negative equity–
Equity ratio–
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Management, owners and auditor

RoleNameFromTo
CEOMartin CaspersenCurrent
Owner (100%)Cap Holding anno 2026 ApSCurrent
FounderCap Holding anno 2026 ApSCurrent

The CEOs' other companies

Martin Caspersen – 2 other companies

Address history (0 moves)

Troldehøj 4, 3200 Helsinge

Other companies at the same address

Similar companies in Gribskov

Questions and answers about Anivana Pharma ApS

Has Anivana Pharma ApS gone bankrupt?

No, Anivana Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Anivana Pharma ApS?

Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.

Who is the CEO of Anivana Pharma ApS?

Martin Caspersen is the CEO of Anivana Pharma ApS.

When was Anivana Pharma ApS founded?

Anivana Pharma ApS was founded on 16 April 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.